Display options
Share it on

Front Neuroanat. 2015 Mar 05;9:23. doi: 10.3389/fnana.2015.00023. eCollection 2015.

Distribution of vesicular glutamate transporters in the human brain.

Frontiers in neuroanatomy

Érika Vigneault, Odile Poirel, Mustapha Riad, Josée Prud'homme, Sylvie Dumas, Gustavo Turecki, Caroline Fasano, Naguib Mechawar, Salah El Mestikawy

Affiliations

  1. Department of Psychiatry, Douglas Mental Health University Institute, McGill University Montreal, QC, Canada.
  2. Institut National de la Santé et de la Recherche Médicale, UMR-S 1130, Neuroscience Paris Seine Paris, France ; Centre National de la Recherche Scientifique UMR 8246, Neuroscience Paris Seine Paris, France ; Sorbonne University, Université Pierre et Marie Curie Paris 06, UM119, Neuroscience Paris Seine Paris, France.
  3. Oramacell Paris, France.
  4. Department of Psychiatry, Douglas Mental Health University Institute, McGill University Montreal, QC, Canada ; Institut National de la Santé et de la Recherche Médicale, UMR-S 1130, Neuroscience Paris Seine Paris, France ; Centre National de la Recherche Scientifique UMR 8246, Neuroscience Paris Seine Paris, France ; Sorbonne University, Université Pierre et Marie Curie Paris 06, UM119, Neuroscience Paris Seine Paris, France.

PMID: 25798091 PMCID: PMC4350397 DOI: 10.3389/fnana.2015.00023

Abstract

Glutamate is the major excitatory transmitter in the brain. Vesicular glutamate transporters (VGLUT1-3) are responsible for uploading glutamate into synaptic vesicles. VGLUT1 and VGLUT2 are considered as specific markers of canonical glutamatergic neurons, while VGLUT3 is found in neurons previously shown to use other neurotransmitters than glutamate. Although there exists a rich literature on the localization of these glutamatergic markers in the rodent brain, little is currently known about the distribution of VGLUT1-3 in the human brain. In the present study, using subtype specific probes and antisera, we examined the localization of the three vesicular glutamate transporters in the human brain by in situ hybridization, immunoautoradiography and immunohistochemistry. We found that the VGLUT1 transcript was highly expressed in the cerebral cortex, hippocampus and cerebellum, whereas VGLUT2 mRNA was mainly found in the thalamus and brainstem. VGLUT3 mRNA was localized in scarce neurons within the cerebral cortex, hippocampus, striatum and raphe nuclei. Following immunoautoradiographic labeling, intense VGLUT1- and VGLUT2-immunoreactivities were observed in all regions investigated (cerebral cortex, hippocampus, caudate-putamen, cerebellum, thalamus, amygdala, substantia nigra, raphe) while VGLUT3 was absent from the thalamus and cerebellum. This extensive mapping of VGLUT1-3 in human brain reveals distributions that correspond for the most part to those previously described in rodent brains.

Keywords: Homo sapiens; VGLUTs; anatomy; brain; glutamate; neurotransmission

References

  1. Brain Behav Immun. 2014 Nov;42:50-9 - PubMed
  2. J Neurosci. 2001 Nov 15;21(22):RC182 - PubMed
  3. Biochimie. 2000 Apr;82(4):327-37 - PubMed
  4. Nature. 2000 Sep 14;407(6801):189-94 - PubMed
  5. Science. 2004 Jun 18;304(5678):1815-9 - PubMed
  6. Neurology. 2010 Jan 19;74(3):259-64 - PubMed
  7. Neurosci Res. 2002 Apr;42(4):243-50 - PubMed
  8. Nat Rev Neurosci. 2011 Apr;12(4):204-16 - PubMed
  9. Biol Psychiatry. 2010 Jun 1;67(11):1010-6 - PubMed
  10. Eur J Neurosci. 2004 Feb;19(3):552-69 - PubMed
  11. J Neurochem. 2000 Jun;74(6):2622-5 - PubMed
  12. Epilepsia. 2009 Jul;50(7):1717-28 - PubMed
  13. J Neurosci. 2006 Nov 22;26(47):12294-307 - PubMed
  14. Bipolar Disord. 2009 Nov;11(7):711-25 - PubMed
  15. Neuron. 2001 Aug 2;31(2):247-60 - PubMed
  16. Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5607-11 - PubMed
  17. J Neurosci. 2006 Nov 15;26(46):12055-66 - PubMed
  18. J Neurochem. 2009 Sep;110(5):1538-46 - PubMed
  19. Curr Opin Pharmacol. 2006 Feb;6(1):114-9 - PubMed
  20. J Neurosci. 1995 Aug;15(8):5789-99 - PubMed
  21. J Neurosci. 2011 Feb 23;31(8):2756-68 - PubMed
  22. J Neurochem. 2006 Aug;98(3):939-50 - PubMed
  23. Prog Brain Res. 1998;116:87-101 - PubMed
  24. Ann N Y Acad Sci. 2003 Nov;1003:438-42 - PubMed
  25. Annu Rev Physiol. 2012;74:225-43 - PubMed
  26. Cereb Cortex. 2009 Jan;19(1):241-8 - PubMed
  27. Ups J Med Sci. 2010 Feb;115(1):11-20 - PubMed
  28. Proc Natl Acad Sci U S A. 2004 May 4;101(18):7158-63 - PubMed
  29. Neuroscience. 2004;123(4):983-1002 - PubMed
  30. Nat Neurosci. 2008 Mar;11(3):292-300 - PubMed
  31. Cereb Cortex. 2004 Nov;14(11):1266-75 - PubMed
  32. EMBO Rep. 2002 Aug;3(8):798-803 - PubMed
  33. J Neurosci. 2001 Nov 15;21(22):RC181 - PubMed
  34. Neuron. 2008 Jan 24;57(2):263-75 - PubMed
  35. Science. 2000 Aug 11;289(5481):957-60 - PubMed
  36. J Neurochem. 1984 Jan;42(1):1-11 - PubMed
  37. J Neurosci. 2004 Nov 17;24(46):10466-74 - PubMed
  38. J Neurosci. 2002 Jan 1;22(1):142-55 - PubMed
  39. J Neurosci. 2010 Feb 10;30(6):2198-210 - PubMed
  40. J Neurosci. 2010 Jun 2;30(22):7634-45 - PubMed
  41. J Neurosci. 1998 Nov 1;18(21):8648-59 - PubMed
  42. Neuropharmacology. 2005 Nov;49(6):901-11 - PubMed
  43. Neurobiol Aging. 2008 Nov;29(11):1619-30 - PubMed
  44. Am J Hum Genet. 2008 Aug;83(2):278-92 - PubMed
  45. Biol Psychiatry. 2008 Apr 15;63(8):766-75 - PubMed
  46. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14488-93 - PubMed
  47. J Neurosci. 2002 Jul 1;22(13):5442-51 - PubMed
  48. Trends Neurosci. 2004 Feb;27(2):98-103 - PubMed
  49. Neuron. 2011 Feb 10;69(3):445-52 - PubMed
  50. Neurobiol Aging. 2007 Apr;28(4):568-78 - PubMed
  51. J Biol Chem. 2002 Dec 27;277(52):50734-48 - PubMed
  52. J Physiol. 2012 Oct 15;590(20):5183-98 - PubMed

Publication Types